One-Pager
Aerosol Drugs and Humidity
Humidifiers and HMEs, choosing a nebulizer, mucoactive and inhaled anti-infective drugs, sequence and stopping rules
Download one-page PDFLetter landscape, ready to print or keep with your notes
Humidity and humidifiers
Inspired gas reaches 37 °C and 44 mg H₂O/L just below the carina. Humidity deficit = 44 − delivered absolute humidity; an artificial airway bypasses the nose's heat and moisture exchange.
| Device | Use | Watch |
|---|---|---|
| Bubble humidifier | Low-flow O₂; consider above 4 L/min | Pop-off whistles if tubing kinks |
| Heated humidifier | Ventilator, HFNC, NIV | 33–44 mg/L at 34–41 °C at the Y |
| Heated-wire circuit | Less rainout | Drain condensate away from patient |
| HME | Short-term ventilation, transport | Adds dead space and resistance |
| Large-volume nebulizer | Trach collar, bland aerosol | Mist must persist on inspiration |
Choosing an aerosol generator
| Device | Strength | Limit |
|---|---|---|
| Jet nebulizer | Any solution; cheap | 0.5–1 mL left behind; adds flow |
| Vibrating mesh | Little residue; adds no flow | Cost; never touch the mesh |
| Ultrasonic | Large volume for sputum induction | Not for suspensions or proteins |
| pMDI with valved chamber | Fast; equals a nebulizer in asthma | Mask under about age 4 |
| Dry powder inhaler | No propellant or spacer | Needs a fast, forceful breath |
Mucoactive and bland aerosols
| Agent | Use | Key point |
|---|---|---|
| Hypertonic saline 7% | CF; non-CF bronchiectasis | Bronchodilator first |
| Hypertonic saline 3% | Sputum induction | Booth or negative-pressure room |
| Dornase alfa 2.5 mg daily | CF only | Never mixed; harmful in non-CF |
| Acetylcysteine 20%, 3–5 mL | Thick secretions | Bronchospasm: give with albuterol |
| Sterile water, saline | Bypassed airway; upper-airway edema | Water can cause bronchospasm |
- AARC 2015: no routine acetylcysteine or bronchodilators to clear secretions, none for postoperative atelectasis, and no mucoactive aerosols for neuromuscular weakness.
- Dornase is given by jet or approved mesh nebulizer, not ultrasonic.
Inhaled anti-infectives and special drugs
| Drug | Regimen | Precautions |
|---|---|---|
| Tobramycin (CF) | 300 mg twice daily, 28 days on, 28 off | Last in the sequence; not mixed |
| Aztreonam (CF) | 75 mg three times daily by its own mesh | Bronchodilator first |
| Pentamidine | 300 mg every 4 weeks, Respirgard II | Negative pressure, filter, TB screen |
| Ribavirin | SPAG-2, 12–18 h a day | Teratogenic: scavenge; no pregnant staff |
| Epoprostenol | Continuous mesh on the ventilator | Clogs filters; never stop abruptly |
Sequence, response and stopping
- CF order: bronchodilator, hypertonic saline, dornase, airway clearance, then inhaled antibiotic or steroid.
- Judge response: breath sounds, peak flow or FEV₁ before and after, heart rate, SpO₂, sputum. No indication or no response: recommend stopping.
- Stop for a sharp heart-rate rise, new arrhythmia, chest pain, paradoxical bronchospasm, desaturation or severe tremor.
- Inhaled steroid thrush or hoarseness: valved chamber, rinse and spit, antifungal; keep the controller.
- Teach by return demonstration (teach-back), not 'do you understand?'
In depth
The one-page summary above is what the PDF prints. These sections go further.
Humidity physics and troubleshooting
Absolute humidity is the water vapor in a volume of gas (mg/L); relative humidity is that content as a percentage of what the gas could hold at its temperature. Warming a saturated gas lowers its relative humidity, and cooling it causes rainout. At 37 °C, saturated gas holds 44 mg/L, so gas delivered at 30 mg/L leaves a humidity deficit of 14 mg/L that the airway must make up. The isothermic saturation boundary normally sits about 5 cm below the carina; dry gas through a tube moves it deeper, drying mucosa, slowing cilia and thickening secretions until they plug the tube.
AARC 2012 calls for humidification in every invasively ventilated patient: 33–44 mg/L at 34–41 °C at the Y-piece from a heated humidifier, or at least 30 mg/L from an HME, which suits short-term use and transport. Heated-wire circuits keep the inspiratory limb warmer than the chamber so less water condenses; if the circuit runs much hotter than the chamber, relative humidity falls and secretions dry. A probe left inside an incubator or under a radiant warmer reads falsely high and the heater turns down.
| Problem | Likely cause | Fix |
|---|---|---|
| Water pooling, coughing with breaths | Rainout in a cool limb | Drain away from patient; check heated wire |
| Thick, dry secretions on an HME | Humidity too low for this patient | Change to a heated humidifier |
| Rising peak pressure on an HME | HME soaked or blocked | Replace it; consider active humidity |
| Low-temperature alarm | Empty chamber, probe off, new circuit | Refill, reseat probe, allow warm-up |
| Bubble humidifier whistling | Kinked or blocked tubing | Find the obstruction; never tape the valve |
Bland aerosol (AARC 2003) has three indications: cool aerosol for upper-airway edema (post-extubation, subglottic), humidity for a bypassed upper airway, and hypertonic or hypotonic saline for sputum induction. Its only listed contraindication is bronchoconstriction. Aerosol is a poorer humidifier for a tracheostomy than a heated humidifier and carries infection risk. Cool mist for croup is traditional but has shown no benefit in trials.
Aerosol generators in detail
Particles of 1–5 µm reach the lower airways; larger ones impact in the mouth and throat, more so with fast breathing, and smaller ones are often exhaled. Jet nebulizers shear liquid with gas at 6–8 L/min from a 4–5 mL fill and leave 0.5–1 mL in the cup; tapping the cup and treating until it sputters extracts more. Breath-enhanced and breath-actuated designs waste less during exhalation.
Vibrating mesh nebulizers push liquid through a plate with thousands of laser-drilled holes. They are quiet, portable, leave little residue and add no gas, which makes them the usual choice on ventilators and for continuous inhaled epoprostenol; because they are efficient, some doses may need adjusting. Ultrasonic nebulizers vibrate a piezoelectric crystal at 1–3 MHz, can warm and degrade drugs, and should not be used for suspensions such as budesonide or for proteins such as dornase. Large-volume ultrasonic units are used for sputum induction.
Continuous albuterol for severe asthma (EPR-3) is 10–15 mg/h in adults and 0.5 mg/kg/h in children, through a large-volume or infusion-fed mesh nebulizer, with cardiac monitoring and potassium checks. Ipratropium mist in the eyes can dilate the pupil and precipitate angle-closure glaucoma, so use a mouthpiece or a well-fitted mask.
Mucoactive drugs and the evidence
Mucolytics break mucus bonds: acetylcysteine splits disulfide bonds and dornase alfa cleaves the DNA released by neutrophils, which is why dornase works in purulent CF sputum. Hypertonic saline is a hyperosmolar expectorant that draws water into the airway surface liquid and raises mucociliary clearance. Acetylcysteine smells of sulfur, irritates the airway and can cause bronchospasm at any dose, so the label advises a nebulized bronchodilator and stopping if bronchospasm progresses; a vial once opened is refrigerated and used within 96 hours.
The CF Foundation (2013) recommends dornase and 7% hypertonic saline for patients 6 years and older. In idiopathic bronchiectasis, dornase given twice daily for 24 weeks increased exacerbations and FEV₁ decline (O'Donnell 1998, 349 patients), so it is not used outside CF. AARC 2015 found no high-level evidence for any aerosol to aid secretion clearance in hospitalized patients without CF and recommends against routine dornase, acetylcysteine and bronchodilators for that purpose.
For a first Pseudomonas aeruginosa culture in CF, the CF Foundation (2014) recommends inhaled tobramycin for eradication, typically 300 mg twice daily for 28 days. Chronic infection is treated with cycles of inhaled tobramycin or aztreonam, given after airway clearance. Inhaled antibiotics need an expiratory filter in hospital to protect staff, and tobramycin is never mixed with dornase in the cup.
Protecting patients and staff
- Pentamidine: 300 mg every 4 weeks by Respirgard II at 5–7 L/min until empty (30–45 minutes). Cough (38%) and bronchospasm (15%) are common, so a bronchodilator is given first if needed. Screen for TB, treat in a negative-pressure booth or room, and use an expiratory filter.
- Ribavirin: SPAG-2 generator only, 20 mg/mL for 12–18 hours a day for 3–7 days. It is contraindicated in anyone who is or may become pregnant, so pregnant staff stay away, a scavenging tent or exhaust is used, and the drug can precipitate in ventilator valves and tubing.
- Sputum induction: a booth or negative-pressure room, an N95 respirator for staff when TB is possible, and a bronchodilator on hand because hypertonic saline can cause bronchospasm.
- Nebulizers are single-patient devices: between treatments clean, rinse with sterile water and air-dry; use sterile fluids and unit-dose vials; at home, clean after every use and disinfect per the manufacturer.
- Valved holding chambers and spacers: wash weekly in warm water with liquid detergent and let them air-dry.
NBRC emphasis and exam pearls
- Thick secretions and an HME: change to a heated humidifier.
- Mist disappears on inspiration from a trach collar: flow is too low for demand.
- Acetylcysteine in an asthmatic: give or pair it with a bronchodilator.
- Dornase: CF only, its own cup, jet or mesh; never ultrasonic.
- Pentamidine: negative pressure, filter, TB screen; ribavirin: pregnancy precautions and scavenging.
- Albuterol with no wheeze and no measurable response: recommend discontinuing it.
- Heart rate jumps with PVCs during albuterol: stop the treatment, stay, monitor, notify.
- Inhaled steroid with thrush: spacer, rinse and spit; do not stop the controller.
Related one-pagers
- ABG Interpretation in 6 StepspH, PaCO₂, HCO₃⁻, compensation, anion gap and oxygenation, with worked examples
- Ventilator Modes and SettingsModes, lung-protective targets, peak vs plateau, alarms and SBT readiness
- ARDSBerlin and Global definitions, lung-protective ventilation, PEEP, proning, paralysis, steroids, ECMO and the nursing care
- Ventilator Liberation and TracheostomySAT and SBT, cuff leak and steroids, HFNC or NIV after extubation, stridor, trach care and NTSP emergencies
- Pulmonary EmbolismESC 2019 and AHA/ACC 2026 risk classes, diagnosis, anticoagulation, lysis, catheter therapy and RV support
- Asthma and COPD ExacerbationsSeverity signs, first treatments, oxygen targets, NIV and ventilating obstructive lungs
Sources
- National Board for Respiratory Care. The Respiratory Therapy Examination Detailed Content Outline, effective January 2027. Link
- Restrepo RD, Walsh BK. Humidification during invasive and noninvasive mechanical ventilation: 2012. Respir Care. 2012;57(5):782-788. Link
- American Association for Respiratory Care. AARC Clinical Practice Guideline: Bland aerosol administration, 2003 revision and update. Respir Care. 2003;48(5):529-533. Link
- Piraino T, Madden M, Roberts KJ, et al. AARC Clinical Practice Guideline: Management of Adult Patients With Oxygen in the Acute Care Setting. Respir Care. 2022;67(1):115-128. Link
- De Vries MJ, Garner SS, Hartley C, Stocking J. Pulmonary Disease Aerosol Delivery Devices: A Guide for Physicians, Nurses, Pharmacists, and Other Health Care Professionals. 4th ed. American Association for Respiratory Care; 2023. Link
- Ari A, Restrepo RD. Aerosol delivery device selection for spontaneously breathing patients: 2012. Respir Care. 2012;57(4):613-626. Link
- Strickland SL, Rubin BK, Haas CF, et al. AARC Clinical Practice Guideline: Effectiveness of Pharmacologic Airway Clearance Therapies in Hospitalized Patients. Respir Care. 2015;60(7):1071-1077. Link
- Mogayzel PJ Jr, Naureckas ET, Robinson KA, et al. Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2013;187(7):680-689. Link
- Mogayzel PJ Jr, Naureckas ET, Robinson KA, et al. Cystic Fibrosis Foundation pulmonary guideline. Pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection. Ann Am Thorac Soc. 2014;11(10):1640-1650. Link
- O'Donnell AE, Barker AF, Ilowite JS, Fick RB. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. Chest. 1998;113(5):1329-1334. Link
- Acetylcysteine solution, USP (inhalation). Prescribing information. DailyMed, US National Library of Medicine. Link
- Pulmozyme (dornase alfa) inhalation solution. Prescribing information, Genentech. DailyMed. Link
- Tobramycin inhalation solution. Prescribing information. DailyMed. Link
- Cayston (aztreonam for inhalation solution). Prescribing information, Gilead Sciences. DailyMed. Link
- NebuPent (pentamidine isethionate) for inhalation. Prescribing information, Fresenius Kabi. DailyMed. Link
- Ribavirin for inhalation solution, USP. Prescribing information. DailyMed. Link
- Tablan OC, Anderson LJ, Besser R, et al. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep. 2004;53(RR-3):1-36. Link
- National Heart, Lung, and Blood Institute. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. 2007. Link
- Johnson DW. Croup. Am Fam Physician. 2016;94(6):476-478 (Clinical Evidence Handbook). Link